SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc.
PVCT 0.0628-3.4%12:12 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: travisnye who wrote (11889)4/18/2013 12:08:00 PM
From: dirkdiggler2 Recommendations  Read Replies (1) of 13111
 
The problem with the stock price is dilution of share price every time they make a new offering for capital your ownership is diluted. Last time they made the preferred share disaster, the price dropped like a rock. They will need to raise a considerable amount of capital for a phase 3; and, phase 3 studies are the most expensive and could run about 4 times as high as a phase 2.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News